Table 2.
Type (%) | Observed regions | Figure no. | AFCL (ms) | Bipolar amplitude (mV) | Bipolar DF (Hz) | Bipolar organization index | MAP amplitude (mV) | MAP DF (Hz) | MAP organization index |
---|---|---|---|---|---|---|---|---|---|
I. Rapid activity (8%) | Pulmonary vein ostia, post left atrium | 2 | 157 ± 10* | 0.26 ± 0.15 | 6.2 ± 0.6 | 0.6 ± 0.1 | 0.6 ± 0.7* | 6.3 ± 0.4† | 0.6 ± 0.2 |
II. Acceleration (8%) | Any site | 3 | 156 ± 32 | 0.43 ± 0.25 | 6.6 ± 1.3 | 0.7 ± 0.2 | 0.9 ± 0.8 | 5.9 ± 0.6 | 0.7 ± 0.2 |
III. Far-field (67%) | Septum, coronary sinus, all sites | 4 | 185 ± 31 | 0.40 ± 0.27 | 5.5 ± 1.1 | 0.6 ± 0.1 | 1.0 ± 0.5 | 5.6 ± 1.0 | 0.7 ± 0.2 |
IV. Disorganized (16%) | Any site | 5 | 183 ± 31 | 0.34 ± 0.24 | 6.0 ± 1.5 | 0.6 ± 0.1 | 0.9 ± 0.8 | 5.6 ± 1.3 | 0.5 ± 0.1 |
V. Not fractionated | Left atrial appendage, right atrial appendage | 1C | 183 ± 41 | 0.55 ± 0.51 | 5.5 ± 1.5 | 0.7 ± 0.2 | 1.5 ± 0.9 | 6.2 ± 2.0 | 0.7 ± 0.2 |
AF = atrial fibrillation; AFCL = atrial fibrillation cycle length; CFAE = complex fractionated; DF = dominant frequency; MAP = monophasic action potential.
P <.05 vs all other CFAE mechanisms.
P <.10 vs all other CFAE mechanisms.